Amphiphilic cyclodextrin nanoparticles.

Area of Science:

• Biochemistry
• Materials Science
• Pharmaceutical Sciences

Background:

• Cyclodextrins are cyclic oligosaccharides with a unique structure featuring a hydrophobic cavity and hydrophilic exterior.
• Their low toxicity and ability to form inclusion complexes make them valuable in pharmaceuticals, primarily for increasing hydrophobic drug solubility.
• Chemically modified cyclodextrins, particularly amphiphilic derivatives, offer enhanced properties for drug delivery applications.

Purpose of the Study:

• To review the applications of amphiphilic cyclodextrins in drug delivery systems.
• To highlight their role in protein, peptide, and gene delivery.
• To emphasize their utility in designing novel nanoparticle-based delivery systems.

Main Methods:

• Synthesis of chemically modified cyclodextrin derivatives, specifically amphiphilic types.
• Formation of self-assembling systems like micelles, vesicles, and nanoparticles.
• Incorporation into lipid membranes for enhanced drug vectorization.

Main Results:

• Amphiphilic cyclodextrins can self-assemble into various supramolecular structures, including nanoparticles.
• These structures effectively encapsulate and deliver hydrophobic drugs, proteins, peptides, and genetic material.
• Improved vectorization and enhanced pharmacological activity are observed with these modified cyclodextrins.

Conclusions:

• Amphiphilic cyclodextrins are versatile tools for developing advanced drug delivery systems.
• Their ability to form nanoparticles is crucial for efficient delivery of challenging therapeutics.
• Further applications in protein, peptide, and gene delivery are promising for novel therapeutic strategies.